rs143978597

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001614.5(ACTG1):​c.414C>T​(p.Ala138Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000439 in 1,613,820 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A138A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00053 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00043 ( 7 hom. )

Consequence

ACTG1
NM_001614.5 synonymous

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -4.39

Publications

3 publications found
Variant links:
Genes affected
ACTG1 (HGNC:144): (actin gamma 1) Actins are highly conserved proteins that are involved in various types of cell motility and in maintenance of the cytoskeleton. Three main groups of actin isoforms have been identified in vertebrate animals: alpha, beta, and gamma. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton and as mediators of internal cell motility. Actin gamma 1, encoded by this gene, is a cytoplasmic actin found in all cell types. Mutations in this gene are associated with DFNA20/26, a subtype of autosomal dominant non-syndromic sensorineural progressive hearing loss and also with Baraitser-Winter syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]
ACTG1 Gene-Disease associations (from GenCC):
  • Baraitser-winter syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss 20
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Baraitser-Winter cerebrofrontofacial syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 17-81511576-G-A is Benign according to our data. Variant chr17-81511576-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128271.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.39 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000525 (80/152378) while in subpopulation AFR AF = 0.000649 (27/41592). AF 95% confidence interval is 0.000458. There are 0 homozygotes in GnomAd4. There are 36 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 80 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001614.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTG1
NM_001614.5
MANE Select
c.414C>Tp.Ala138Ala
synonymous
Exon 4 of 6NP_001605.1P63261
ACTG1
NM_001199954.3
c.414C>Tp.Ala138Ala
synonymous
Exon 4 of 6NP_001186883.1P63261
ACTG1
NR_037688.3
n.486C>T
non_coding_transcript_exon
Exon 4 of 7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTG1
ENST00000573283.7
TSL:5 MANE Select
c.414C>Tp.Ala138Ala
synonymous
Exon 4 of 6ENSP00000458435.1P63261
ACTG1
ENST00000575842.5
TSL:1
c.414C>Tp.Ala138Ala
synonymous
Exon 3 of 5ENSP00000458162.1P63261
ACTG1
ENST00000615544.5
TSL:1
c.414C>Tp.Ala138Ala
synonymous
Exon 4 of 6ENSP00000477968.1P63261

Frequencies

GnomAD3 genomes
AF:
0.000532
AC:
81
AN:
152260
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000651
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000411
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000559
AC:
140
AN:
250458
AF XY:
0.000627
show subpopulations
Gnomad AFR exome
AF:
0.000437
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00219
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000513
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000430
AC:
629
AN:
1461442
Hom.:
7
Cov.:
37
AF XY:
0.000476
AC XY:
346
AN XY:
727018
show subpopulations
African (AFR)
AF:
0.000627
AC:
21
AN:
33476
American (AMR)
AF:
0.000447
AC:
20
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00191
AC:
50
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00132
AC:
114
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53022
Middle Eastern (MID)
AF:
0.0184
AC:
106
AN:
5768
European-Non Finnish (NFE)
AF:
0.000247
AC:
275
AN:
1111976
Other (OTH)
AF:
0.000679
AC:
41
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
40
80
121
161
201
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000525
AC:
80
AN:
152378
Hom.:
0
Cov.:
33
AF XY:
0.000483
AC XY:
36
AN XY:
74518
show subpopulations
African (AFR)
AF:
0.000649
AC:
27
AN:
41592
American (AMR)
AF:
0.000327
AC:
5
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000412
AC:
28
AN:
68042
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000359
Hom.:
0
Bravo
AF:
0.000544
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000709
EpiControl
AF:
0.000889

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
not specified (2)
-
-
1
ACTG1-related disorder (1)
-
-
1
Autosomal dominant nonsyndromic hearing loss 20 (1)
-
-
1
Autosomal dominant nonsyndromic hearing loss 20;C3281235:Baraitser-winter syndrome 2 (1)
-
-
1
Baraitser-winter syndrome 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_noAF
Benign
-0.80
CADD
Benign
6.1
DANN
Benign
0.91
PhyloP100
-4.4
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143978597; hg19: chr17-79478602; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.